Avenue Therapeutics Stock Shares Outstanding
| ATXIDelisted Stock | USD 0.36 0.02 5.26% |
Avenue Therapeutics fundamentals help investors to digest information that contributes to Avenue Therapeutics' financial success or failures. It also enables traders to predict the movement of Avenue Pink Sheet. The fundamental analysis module provides a way to measure Avenue Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avenue Therapeutics pink sheet.
Avenue |
Avenue Therapeutics Company Shares Outstanding Analysis
Avenue Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Avenue Therapeutics Shares Outstanding | 2.05 M |
Most of Avenue Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avenue Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Avenue Therapeutics has 2.05 M of shares currently outstending. This is 98.86% lower than that of the Pharmaceuticals sector and 98.08% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.64% higher than that of the company.
Avenue Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avenue Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Avenue Therapeutics could also be used in its relative valuation, which is a method of valuing Avenue Therapeutics by comparing valuation metrics of similar companies.Avenue Therapeutics is currently under evaluation in shares outstanding category among its peers.
Avenue Fundamentals
| Return On Equity | -5.35 | ||||
| Return On Asset | -4.72 | ||||
| Current Valuation | (1.73 M) | ||||
| Shares Outstanding | 2.05 M | ||||
| Shares Owned By Insiders | 25.23 % | ||||
| Shares Owned By Institutions | 15.32 % | ||||
| Number Of Shares Shorted | 92.16 K | ||||
| Price To Earning | (10.52) X | ||||
| Price To Book | 0.33 X | ||||
| EBITDA | 4.05 M | ||||
| Net Income | (10.38 M) | ||||
| Cash And Equivalents | 890 K | ||||
| Cash Per Share | 0.60 X | ||||
| Total Debt | 1.2 M | ||||
| Debt To Equity | 23.40 % | ||||
| Current Ratio | 2.47 X | ||||
| Book Value Per Share | 1.63 X | ||||
| Cash Flow From Operations | (9.45 M) | ||||
| Short Ratio | 0.65 X | ||||
| Earnings Per Share | 24.78 X | ||||
| Target Price | 8.0 | ||||
| Beta | -0.29 | ||||
| Market Capitalization | 862.65 K | ||||
| Total Asset | 1.85 M | ||||
| Retained Earnings | (90.93 M) | ||||
| Working Capital | 654 K | ||||
| Current Asset | 111.05 K | ||||
| Current Liabilities | 4.67 M | ||||
| Net Asset | 1.85 M |
About Avenue Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avenue Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avenue Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avenue Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Avenue Pink Sheet
If you are still planning to invest in Avenue Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avenue Therapeutics' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |